Fig. 3From: Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysisOutcome of HLA-matched sibling donor (MSD) and haploidentical donor (HID) groups. Cumulative incidence of non-relapse mortality A, and relapse (B). Probabilities of overall survival (C), relapse-free survival (D), and GVHD-free and relapse-free survival (E). Overall survival of patients in first complete remission with negative MRD (F) and positive MRD (G) at transplant. GVHD graft-versus-host disease, MRD measurable residual diseaseBack to article page